Zhenhua Yin

Zhenhua Yin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Zhenhua Yin has a total of 46 co-authors. Here are the top co-authors by number of shared publications:

  • Wenyi Kang

    National R & D Center for Edible Fungus Processing Technology, Henan University, Kaifeng 475004, China

    9 shared publications
  • Juanjuan Zhang

    Henan Engineering Research Center of Chemistry and Biology of Medicinal Resources, Henan Comprehensive Utilization of Edible and Medicinal Plant Resources Engineering Technology Research Center, Zhengzhou Key Laboratory of Synthetic Biology of Natural Products, Henan Joint International Research Laboratory of Drug Discovery of Small Molecules, Huanghe Science and Technology College, Zhengzhou 450063, China

    8 shared publications
  • Lin Chen

    Comprehensive Utilization of Edible and Medicinal Plant Resources Engineering Technology Research Center, Zhengzhou Key Laboratory of Synthetic Biology of Natural Products, Huanghe Science and Technology College, Zhengzhou 450006, China

    7 shared publications
  • Qingfeng Guo

    Henan Engineering Research Center of Chemistry and Biology of Medicinal Resources, Henan Comprehensive Utilization of Edible and Medicinal Plant Resources Engineering Technology Research Center, Zhengzhou Key Laboratory of Synthetic Biology of Natural Products, Henan Joint International Research Laboratory of Drug Discovery of Small Molecules, Huanghe Science and Technology College, Zhengzhou 450063, China

    6 shared publications
  • Wei Zhang

    Zhengzhou Key Laboratory of Medicinal Resources Research, Huanghe Science and Technology College, Zhengzhou 450063, China

    5 shared publications
  • Baocheng Yang

    Henan Key Laboratory of Nanocomposite and Applications, Institute of Nanostructured Functional Materials, Huanghe Science and Technology College, Zhengzhou, China

    3 shared publications

Latest Publications

  • Open Access

    Dual Modulation of Lipid Metabolism by Adzuki Bean (Vigna angularis) Saponins Involving PPARα/γ Signaling and Gut Microbiota Remodeling in Obesogenic Diet-Induced Obese Mice

    by Qingfeng Guo, Jinhai Luo, Xia Zhang, Hao Zhang, Meiru Chen, Man Liu, Zhenhua Yin, Juanjuan Zhang, Baocheng Yang, Li Wang, et al.

    Obesity is a prevalent metabolic disorder characterized by excessive lipid accumulation. This study aimed to investigate the anti-obesity effects and underlying mechanisms of two triterpenoid saponin-rich extracts, designated disaccharide saponin-rich extract (DTS) and trisaccharide/tetrasaccharide saponin-rich extract (TTS), prepared from adzuki bean (Vigna angularis). In vitro, both DTS and TTS extracts significantly inhibited lipid accumulation in 3T3-L1 adipocytes without cytotoxicity, with TTS reducing lipid droplets to 21.45% of the model group at 200 μg/mL. In vivo, C57BL/6J mice were fed a high-fat–high-cholesterol diet (HFD) for 12 weeks and orally administrated with DTS or TTS (30, 60, or 120 mg/kg/day) via gavage; the results showed marked reductions in body weight gain (up to 20.37%), fat mass, liver coefficient, and serum levels of total cholesterol (TC), triglyceride (TG), Low-Density Lipoprotein Cholesterol (LDL-C), Alanine Aminotransferase (ALT), and Aspartate Aminotransferase (AST), while elevating high-density lipoprotein cholesterol (HDL-C) levels. Mechanistically, transcriptomics and Western blot analyses revealed that both extracts were associated with upregulation of the PPARα-ACOX1 axis, consistent with enhanced fatty acid β-oxidation, and downregulation of the PPARγ-FABP4 pathway, consistent with reduced adipogenesis, suggesting a dual shift toward lipid catabolism and away from lipid synthesis. Furthermore, 16S rRNA sequencing demonstrated that both saponin extracts reversed HFD-induced gut dysbiosis by restoring α-diversity and orchestrating distinct genus-level modulations, specifically suppressing obesity-associated pathobionts (Faecalibaculum and Ileibacterium) while concurrently enriching beneficial commensals (Bifidobacterium). Notably, TTS at 120 mg/kg reduced body weight gain to a greater extent than the positive control orlistat (p < 0.05, Tukey’s HSD), with comparable improvements in serum lipid profiles and liver function parameters. Collectively, these findings demonstrate that adzuki bean saponin extracts exert anti-obesity effects in HFD-fed mice and are associated with multi-target changes involving the “liver–adipose–gut axis,” supporting their further evaluation as candidate as functional food ingredients for metabolic health.

  • Open Access

    α-Glucosidase and Pancreatic Lipase Inhibitory Activity of Chemical Constituents from Adzuki Bean (Vigna angularis)

    by Qingfeng Guo, Xia Zhang, Hao Zhang, Mengxue Wang, Haoran Zhou, Meiru Chen, Zhenhua Yin, Juanjuan Zhang, Baocheng Yang, Li Wang, et al.

    Originating in East Asia, the adzuki bean (Vigna angularis) is a diploid crop mainly grown in this region that belongs to the Fabaceae family. As a potential functional food resource with both medicinal and nutritional value, it offers various health benefits. However, research on its chemical constituents, particularly key bioactive components such as triterpenoid saponins and flavonoids, remains relatively limited. In this study, a new triterpenoid saponin, adzukisaponin A (1), along with eleven known compounds (2–12), were isolated from adzuki bean (V. angularis). Among them, compounds 3 (yunganoside B1), 6 (3β-acetyl oleanolic acid), and 7 (β-amyrin) are reported from this source for the first time. Saponins 1–3 and flavonoid 8 exhibited significant dual inhibitory activity. Notably, saponins 1–3 inhibited pancreatic lipase (IC50 = 0.11 ± 0.18 to 0.40 ± 0.21 mM) more strongly than the positive control orlistat, while also acting against α-glucosidase (IC50 = 0.14 ± 0.11 to 0.23 ± 0.17 mM). Molecular docking supported their binding to the enzymes’ active sites. This study identifies 1–3 and 8 as dual α-glucosidase/pancreatic lipase inhibitors, underscoring the potential of adzuki bean as a source of bioactive functional food ingredients.


  • Open Access

    The Content Variation of Four Active Components in Amygdalus persica L. during Different Harvesting Periods

    by Juanjuan Zhang, Xudong Chen, Zhenhua Yin, Qinfeng Guo, Baocheng Yang, Miaoqing Feng, Xiao Li, Lin Chen, Wei Zhang, Wenyi Kang

    The Content Variation of Four Active Components in Amygdalus persica L. during Different Harvesting Periods: In this study, a quantitative method for the content determination of rutin, 5-O-coumaroylquinic acid methyl ester, chlorogenic acid butyl ester, and kaempferol in Amygdalus persica L. flowers during different harvest periods was established to investigate its various rules and determine the optimal harvesting period. The determination was performed on the XTERRA MS C18 column with a mobile phase consisting of 0.1 formic acid aqueous solution and acetonitrile (gradient elution) at a flow rate of 1.0mL/min. In combination with other validation data, including precision, stability, and recovery tests, this method demonstrated good reliability and sensitivity. The results showed that the contents of rutin, 5-O-coumaroylquinic acid methyl ester, chlorogenic acid butyl ester, and kaempferol in A. persica flowers during different harvest periods were quite different, and the content in samples at the early blooming stage was the highest. The method is simple, accurate, and rapid for determining the contents of four active ingredients in A. persica flowers.


  • Open Access

    Chemical Constituents and Coagulation Activity of Amygdalus persica L. Flowers

    by Juanjuan Zhang, Zhenhua Yin, Lin Chen, Baocheng Yang, Wei Zhang, Wenyi Kang

    Amygdalus persica L., belongs to Rosaceae family, and its flowers are used as medicine and food. n-Butanol extract of A. persica flowers were isolated and purified with various column chromatographies, and the fourteen compounds, chlorogenic acid butyl ester (1), rutin (2), protocatechuic acid (3), caffeic acid (4), 5-O-coumarroylquinic acid methyl ester (5), kaempferol-3-O-neohesperidoside (6), quercetin-3-O-β-D-glucoside (7), 3,5-dicaffeoylquinic acid (8), quercetin-3-O-α-L-rhamnoside (9), 5-O-coumaroylquinic acid (10), kaempferol-3-O-α-L-rhamnoside (11), kaempferol-3-O-β-D-galactoside (12), D-glucitol (13), and multiflorin A (14), were identified by spectroscopic data and physical data. All the compounds except compound 2 were identified from A. persica flowers for the first time. The compounds were investigated for their coagulation activity by activated partial thromboplastin time (APTT), prothrombin time (PT), thrombin time (TT), and bibrinogen (FIB) in vitro. The results of coagulation activity showed that rutin (2), caffeic acid (4), kaempferol-3-O-neohesperidoside (6), kaempferol-3-O-α-L-rhamnoside (11), and kaempferol-3-O-β-D-galactoside (12) exhibited significant procoagulant activity, while chlorogenic acid butyl ester (1) possessed anticoagulant activity in vitro.


  • Open Access

    Identification of ALDH3A2 as a novel prognostic biomarker in gastric adenocarcinoma using integrated bioinformatics analysis

    by Zhenhua Yin, Dejun Wu, Jianping Shi, Xiyi Wei, Nuyun Jin, Xiaolan Lu, Xiaohan Ren

    Background: Extensive research has revealed that genes play a pivotal role in tumor development and growth. However, the underlying involvement of gene expression in gastric carcinoma (GC) remains to be investigated further. Methods: In this study, we identified overlapping differentially expressed genes (DEGs) by comparing tumor tissue with adjacent normal tissue using the Gene Expression Omnibus (GEO) and the Cancer Genome Atlas (TCGA) database. Results: Our analysis identified 79 up-regulated and ten down-regulated genes. Functional enrichment analysis and prognosis analysis were conducted on the identified genes, and the fatty aldehyde dehydrogenase (FALDH) gene, ALDH3A2, was chosen for more detailed analysis. We performed Gene Set Enrichment Analysis (GSEA) and immunocorrelation analysis (infiltration, copy number alterations, and checkpoints) to elucidate the mechanisms of action of ALDH3A2 in depth. The immunohistochemical (IHC) result based on 140 paraffin-embedded human GC samples indicated that ALDH3A2 was over-expressed in low-grade GC cases and the OS of patients with low expression of ALDH3A2 was significantly shorter than those with high ALDH3A2 expression. In vitro results indicated that the expression of ALDH3A2 was negatively correlated with PDCD1, PDCD1LG2, and CTLA-4. Conclusion: We conclude that ALDH3A2 might be useful as a potential reference value for the relief and immunotherapy of GC, and also as an independent predictive marker for the prognosis of GC.


  • Open Access

    Anticancer Effects and Mechanisms of Action of Plumbagin: Review of Research Advances

    by Zhenhua Yin, Juanjuan Zhang, Lin Chen, Qingfeng Guo, Baocheng Yang, Wei Zhang, Wenyi Kang

    Plumbagin (PLB), a natural naphthoquinone constituent isolated from the roots of the medicinal plant Plumbago zeylanica L., exhibited anticancer activity against a variety of cancer cell lines including breast cancer, hepatoma, leukemia, melanoma, prostate cancer, brain tumor, tongue squamous cell carcinoma, esophageal cancer, oral squamous cell carcinoma, lung cancer, kidney adenocarcinoma, cholangiocarcinoma, gastric cancer, lymphocyte carcinoma, osteosarcoma, and canine cancer. PLB played anticancer activity via many molecular mechanisms, such as targeting apoptosis, autophagy pathway, cell cycle arrest, antiangiogenesis pathway, anti‐invasion, and antimetastasis pathway. Among these signaling pathways, the key regulatory genes regulated by PLB were NF‐kβ, STAT3, and AKT. PLB also acted as a potent inducer of reactive oxygen species (ROS), suppressor of cellular glutathione, and novel proteasome inhibitor, causing DNA double‐strand break by oxidative DNA base damage. This review comprehensively summarizes the anticancer activity and mechanism of PLB.


  • Open Access

    Two Novel Polysaccharides in Psoralea corylifolia L and anti-A549 Lung Cancer Cells Activity In Vitro

    by Zhenhua Yin, Wei Zhang, Juanjuan Zhang, Huili Liu, Qingfeng Guo, Lin Chen, Jinmei Wang, Wenyi Kang

    Two novel water soluble heteroglycan (PCp-I and PCp-II) with anti-A549 lung cancer cells activity were isolated from Psoralea corylifolia L. Their average molecular weights were 2.721 × 104 and 2.850 × 104. PCp-I and PCp-II had the same monosaccharide composition, but their molar ratios were different. Based on methylation and NMR spectroscopy, the part structure of PCp-I was identified. The results of scanning electron microscope (SEM) showed that PCp-I had an irregular porous structure and PCp-II was flaky and irregularly curved. The results of thermogravimetry-differential scanning calorimetry (TG-DSC) showed that PCp-I and PCp-II had good thermal stability. Furthermore, PCp-I and PCp-II exhibited significant anti-A549 lung cancer cells activity (IC50 = 64.84 and 126.30 μM) in vitro.


  • Open Access

    Chaetomadrasins A and B, Two New Cytotoxic Cytochalasans from Desert Soil-Derived Fungus Chaetomium madrasense 375

    by Qing-Feng Guo, Zhen-Hua Yin, Juan-Juan Zhang, Wen-Yi Kang, Xue-Wei Wang, Gang Ding, Lin Chen

    Two new cytochalasans, Chaetomadrasins A (1) and B (2), along with six known analogues (3–8), were isolated from the solid-state fermented culture of desert soil-derived Chaetomium madrasense 375. Their structures were clarified by comprehensive spectroscopic analyses, and the absolute configurations of Compounds 1 and 2 were confirmed by electronic circular dichroism (ECD) and calculated ECD. For the first time, Chaetomadrasins A (1), which belongs to the chaetoglobosin family, is characterized by the presence of all oxygen atoms in the form of Carbonyl. Chaetomadrasin B (2) represents the first example of chaetoglobosin type cytochalasan characterized by a hydroxy unit and carbonyl group fused to the indole ring. Compounds 1 and 2 displayed moderate cytotoxicity against HepG2 human hepatocellular carcinoma cells.


  • Two Compounds Isolated From Ganglioside GM1 Promote Angiogenesis in Zebrafish

    by Yunwei Shi, Xiaoning Wang, Yuanyuan Shi, Jie Zhang, Shuyong Zhao, Zhenhua Yin, Guangmin Xu, Xuchu Duan, Zhimou Guo, Xinmiao Liang, et al.

    Ganglioside has been implicated to play important roles in modulating various cell signaling and biological functions. However, the functional analysis of a single ganglioside in a zebrafish model is so far lacking. In this study, we investigated the angiogenic effects of 2 monosialoganglioside compounds isolated from GM1 in zebrafish embryos. First, we showed the tested compounds are adequate safe. Then, we found that these compounds exhibited significant proangiogenic effect through enhancement of endothelial cell proliferation, migration, and differentiation. Furthermore, the 2 compounds were proved to promote angiogenesis through, at least partially, modulating the level of Notch signaling. This study provides the novel insights into the clinical application of the 2 ganglioside compounds and GM1.


  • Open Access

    Pharmacological Effects of Verticine: Current Status

    by Zhenhua Yin, Juanjuan Zhang, Qingfeng Guo, Lin Chen, Wei Zhang, Wenyi Kang

    Verticine is the major bioactive constituent of Fritillaria as a kind of Traditional Chinese Medicine. Pharmacological researches have reported various benefits of verticine, including anticancer, anti-inflammatory, protecting against acute lung injury, tracheobronchial relaxation, antitussive, expectorant, sedative, and analgesic activities, in addition to inhibiting proliferation of cultured orbital fibroblast, angiotensin converting enzyme (ACE), and acetylcholinesterase (AChE) and inhibiting hERG potassium channels. The underlying mechanisms of verticine are still under investigation. This review will comprehensively summarize the metabolism, biological activities, and possible mechanism of verticine.